Advantage India
Cost
Efficiency
* Low cost of production and R&D boosts efficiency of Indian pharma companies, leading to competitive exports.
* Indian drugs and pharma exports reached US$ 5.78 billion between April 2021- June 2021.

Economic
Drivers
* High economic growth along with increasing penetration of health insurance to push expenditure on healthcare and medicine in India.

policy
Support
* In June 2021, Finance Minister Ms. Nirmala Sitharaman announced an additional outlay of Rs. 197,000 crore (US$ 26,578.3 million) that will be utilised over five years for the pharmaceutical PLI scheme in 13 key sectors such as active pharmaceutical ingredients, drug intermediaries and key starting materials.

Increasing
Investment
* The FDI inflows in the Indian drugs and pharmaceuticals sector reached US$ 1.206 billion between April-December 2021.

Major states for Pharmaceuticals
- Karnataka
- Maharashtra
- Gujarat
- Uttar Pradesh
- Delhi NCR
- Tamil Nadu
- Telangana

IBEF Campaigns
MORE
Experience India - Dubai Expo 2020
From the small towns and districts of India come the big-hearted artists wh...

Geographical Indicators of India
The Geographical Indications Registry is set up for administration of the G...
Case Studies
MOREIBEF BLOG
MOREIndia – Global hub of Therapy
Introduction India has one of the oldest healthcare systems in the world, ...
India's AR/VR Market
Introduction Advanced technology is gaining prominence across the globe, e...
India's Energy Transition and Innovation Collaboration
Introduction The global coal power generation nearly doubled during 2005&n...